Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Sell
3,014
-25
-0.8% -$2.73K 0.05% 25
2026
Q1
$252K Sell
3,039
-1,122
-27% -$96.1K 0.04% 29
2025
Q4
$356K Sell
4,161
-24,173
-85% -$2.02M 0.06% 29
2025
Q3
$2.37M Sell
28,334
-1,457
-5% -$133K 0.36% 29
2025
Q2
$3.02M Buy
29,791
+1,388
+5% +$142K 0.44% 29
2025
Q1
$3.02M Sell
28,403
-1,606
-5% -$166K 0.48% 26
2024
Q4
$3.29M Buy
30,009
+4,206
+16% +$489K 0.51% 27
2024
Q3
$3.74M Sell
25,803
-50
-0.2% -$6.82K 0.58% 23
2024
Q2
$3.77M Sell
25,853
-10,055
-28% -$1.41M 0.6% 27
2024
Q1
$5.16M Sell
35,908
-3,280
-8% -$374K 0.89% 15
2023
Q4
$3.66M Buy
39,188
+1,435
+4% +$132K 0.61% 22
2023
Q3
$3.33M Buy
37,753
+13,209
+54% +$1.36M 0.62% 19
2023
Q2
$2.76M Buy
24,544
+1,918
+8% +$229K 0.52% 20
2023
Q1
$2.86M Sell
22,626
-8,320
-27% -$1.01M 0.59% 19
2022
Q4
$3.36M Buy
30,946
+865
+3% +$76.5K 0.72% 15
2022
Q3
$2.06M Sell
30,081
-575
-2% -$39.9K 0.49% 20
2022
Q2
$1.49M Buy
30,656
+10,581
+53% +$642K 0.33% 29
2022
Q1
$1.53M Buy
+20,075
New +$1.9M 0.33% 27

Other funds holding CROX

McMorgan & Co's CROX Position: Q2 2026 in Review

McMorgan & Co reduced its Crocs (CROX) stake by 0.82% in Q2 2026, selling an estimated $2.73K and leaving 3,014 shares worth $364K. The position accounts for 0.05% of the portfolio, ranked #25.

McMorgan & Co first reported a position in CROX in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.16M in Q1 2024. 501 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • McMorgan & Co held 3,014 shares of Crocs worth $364K as of Q2 2026.
  • McMorgan & Co sold 25 Crocs shares in Q2 2026, an estimated $2.73K.
  • Crocs made up 0.05% of McMorgan & Co's portfolio in Q2 2026, its #25 holding.
  • McMorgan & Co first reported a position in Crocs in Q1 2022 and has held it in 18 quarters since.
  • McMorgan & Co's Crocs position peaked at $5.16M in Q1 2024.
  • 501 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on McMorgan & Co's 13F filing for Q2 2026, filed 14 Aug 2026.